MENU
+Compare
RNTX
Stock ticker: NASDAQ
AS OF
Sep 26, 04:59 PM (EDT)
Price
$1.18
Change
-$0.02 (-1.67%)
Capitalization
28.71M

RNTX Rein Therapeutics Inc Forecast, Technical & Fundamental Analysis

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

RNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RNTX with price predictions
Sep 25, 2025

RNTX in +6.70% Uptrend, advancing for three consecutive days on September 25, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where RNTX advanced for three days, in of 213 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where RNTX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 24, 2025. You may want to consider a long position or call options on RNTX as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RNTX just turned positive on September 25, 2025. Looking at past instances where RNTX's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 131 cases where RNTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

RNTX moved below its 50-day moving average on September 10, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RNTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RNTX broke above its upper Bollinger Band on August 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.542) is normal, around the industry mean (19.661). P/E Ratio (0.000) is within average values for comparable stocks, (53.961). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.097). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (344.769).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RNTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RNTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of stapled peptide drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRAX52.002.75
+5.58%
Praxis Precision Medicines
SNYR2.500.04
+1.63%
Synergy CHC Corp
ADSK322.802.63
+0.82%
Autodesk
TLSI4.70-0.07
-1.37%
TriSalus Life Sciences
ENPH36.48-0.60
-1.62%
Enphase Energy

RNTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RNTX has been loosely correlated with SRZN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RNTX jumps, then SRZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNTX
1D Price
Change %
RNTX100%
+0.42%
SRZN - RNTX
44%
Loosely correlated
+1.49%
INAB - RNTX
31%
Poorly correlated
N/A
ERNA - RNTX
28%
Poorly correlated
-0.88%
CGTX - RNTX
28%
Poorly correlated
-6.67%
WHWK - RNTX
28%
Poorly correlated
-1.05%
More